Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Kentaro Miyoshi"'
Publikováno v:
JA Clinical Reports, Vol 8, Iss 1, Pp 1-2 (2022)
Externí odkaz:
https://doaj.org/article/14c63bbc4341409790635a063f507969
Publikováno v:
Biochemical and Biophysical Research Communications. 643:96-104
Publikováno v:
Biochemical and biophysical research communications. 643
Opioids are highly potent analgesics but develop tolerance. Previous studies have focused on phosphorylation of the μ-opioid receptor as it is involved in maintaining cellular sensitivity via desensitization, recycling, and degradation of the activa
Publikováno v:
SSRN Electronic Journal.
Autor:
Kentaro Miyoshi, Toshio Shiotani, K. Matsubara, Seiichiro Sugimoto, Yasuaki Tomioka, S. Toyooka, Haruchika Yamamoto, D. Shimizu, M. Okazaki, M. Yamane, S. Ohtani
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S346-S347
Purpose Renal dysfunction is a well-known long-term complication which could increase mortality after non-renal solid organ transplantation. Recently, the UNCX variant (rs10277115), which encodes a paired-type homeobox transcription factor and has es
Autor:
K. Matsubara, Haruchika Yamamoto, Shinji Otani, Yasuaki Tomioka, Toshio Shiotani, Kentaro Miyoshi, Seiichiro Sugimoto, S. Toyooka, M. Okazaki, D. Shimizu, M. Yamane
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S306
Purpose Chronic lung allograft dysfunction (CLAD) is known as one of the major fatal disorders in the long-term phase after lung transplantation. Because CLAD is a heterogeneous disease, proper classification of phenotypes is important to understand
Autor:
D. Shimizu, K. Matsubara, Kentaro Nakata, Haruchika Yamamoto, M. Okazaki, M. Yamane, Shinji Otani, Seiichiro Sugimoto, S. Toyooka, Toshio Shiotani, Yasuaki Tomioka, Kentaro Miyoshi
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S149
Purpose Histidine-rich glycoprotein (HRG) is a 75 kDa plasma glycoprotein produced in and secreted from the liver. Recently, supplementary HRG treatment has been shown to inhibit acute respiratory distress syndrome (ARDS) and prevent septic lethality
Autor:
D. Shimizu, Kentaro Miyoshi, M. Okazaki, Shinji Otani, K. Matsubara, M. Yamane, S. Toyooka, Haruchika Yamamoto, Toshio Shiotani, Etsuji Suzuki, Seiichiro Sugimoto, Yasuaki Tomioka
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S358
Purpose Recently, various disciplines have recognized the importance of preoperative nutritional and inflammatory status in influencing postoperative clinical outcomes. However, the usefulness of existing prognostic scoring methods has not yet been v
Autor:
Toshio Shiotani, M. Okazaki, Shinji Otani, D. Shimizu, Kentaro Miyoshi, M. Yamane, Haruchika Yamamoto, S. Toyooka, Seiichiro Sugimoto, Yasuaki Tomioka
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S312
Purpose Post-transplant lymphoproliferative disorder (PTLD) affects 3-9% of lung transplant (LTx) recipients, with a mortality range of 20-50%. Despite this high morbidity and mortality, few large studies on Asian population are reported, therefore,
Autor:
Y. Yoshizaki, Shinji Otani, T. Ito, Takahiro Oto, Kento Yamamoto, Yutaka Hirano, M. Irie, Takeshi Kurosaki, Kentaro Miyoshi, R. Nakanishi, Manabu Suno, K. Sakamoto, Seiichiro Sugimoto, Masaomi Yamane
Publikováno v:
Transplantation Proceedings. 48:271-274
Purpose Sirolimus (SRL) is used to treat pulmonary lymphangioleiomyomatosis (P-LAM). There is limited evidence that SRL has systemic efficacy for the patients with extrapulmonary lymphangioleiomyomatosis (E-LAM) remaining after lung transplantation (